Adagene ADAG
NASDAQ ADAG
$3.62 -0.07 (-1.89%)
As of: Sep 4, 2026 · 2:49 PM EDT

Adagene (ADAG) Accumulated Expenses (2019 - 2026)

Adagene (ADAG) posted quarterly Accumulated Expenses of $2790.8 billion for Q4 2025, down 0.9% year-over-year from $2816.0 billion in Q4 2024, and up 75913576.7% quarter-over-quarter from $3.7 million in Q2 2025.

Analysis

Adagene (ADAG) Accumulated Expenses (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Accumulated Expenses for 7 consecutive years, with $2790.8 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accumulated Expenses fell 0.9% year-over-year to $2790.8 billion; the TTM figure through Dec 2025 stood at $2790.8 billion (down 0.9% YoY), while the FY2025 annual figure was $2790.8 billion, down 0.9% from the prior year.
  • Accumulated Expenses rose to $2790.8 billion in Q4 2025 per ADAG's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $4237.6 billion in Q2 2022 and bottomed at $2.7 million in Q2 2024.
  • Historically, Accumulated Expenses has averaged $1889.3 billion across 5 years, with a median of $2803.4 billion in 2024.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 119089996.15% — and 2024, when it sank 100.0%.
  • Adagene's Accumulated Expenses stood at $4.4 million in 2021, then soared by 73364383.31% to $3212.8 billion in 2022, then fell by 6.58% to $3001.5 billion in 2023, then retreated by 6.18% to $2816.0 billion in 2024, then fell by 0.9% to $2790.8 billion in 2025.
  • Business Quant data shows ADAG's Accumulated Expenses at $2790.8 billion in Q4 2025, $3.7 million in Q2 2025, and $2816.0 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Adagene 213.60 Mn 213.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.58 Mn
Dec 31, 2025 2.79 Mn
Jun 30, 2025 3.68 Mn
Dec 31, 2024 2.82 Mn
Jun 30, 2024 2.66 Mn
Dec 31, 2023 3.00 Mn
Jun 30, 2023 2.83 Mn
Dec 31, 2022 3.21 Mn
Jun 30, 2022 4.24 Mn
Dec 31, 2021 4.38 Mn
Jun 30, 2021 3.56 Mn
Dec 31, 2020 6.06 Mn
Dec 31, 2019 2.54 Mn